eribulin brands

1 registered brand containing eribulin in South Africa.

Molecular formula: C40H59NO11

Eribulin inhibits the growth phase of microtubules without affecting the shortening phase and sequesters tubulin into nonproductive aggregates. Eribulin exerts its effects via a tubulin-based antimitotic mechanism leading to G2/M cell-cycle block, disruption of mitotic spindles, and, ultimately, apoptotic cell death after prolonged mitotic blockage. [FDA]

Source: PubChem (NCBI) ยท compound 11354606

Product Manufacturer Status Country
ERIBULIN DRL - Registered South Africa